Home
About
Overview
Sharing Data
ORCID
Help
History (9)
Venombin A
Can molecular profiling of cytogenetic subgroups draw a roadmap for individualizing therapy in myelodysplastic syndromes?
High-Parameter Mass Cytometry Evaluation of Relapsed/Refractory Multiple Myeloma Patients Treated with Daratumumab Demonstrates Immune Modulation as a Novel Mechanism of Action.
Relations of circulating resistin and adiponectin and cardiac structure and function: the Framingham Offspring Study.
Medical Director, Cancer Research Office (CRO)
See All 9 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Medical Director, Cancer Research Office (CRO)
2011 -
2012
Medical Director, Cancer Research Office (CRO)